The findings suggest that reconsideration of current clinical guidelines, which support MRI only for symptomatic brain ...

Several studies show that isolation is very common among those diagnosed with metastatic breast cancer. However, there are ...

If you have metastatic breast cancer, you may need help from loved ones and your medical team along the way. Here’s how to ...

After living with metastatic breast cancer for 11 years, I reflect on my journey and plan to embrace the coming year with ...

DelveInsight’s, “Metastatic Breast Cancer Pipeline Insight” report provides comprehensive insights about 100+ companies and ...

The immediate threat has passed, at least for now. But concern from individuals, businesses, nonprofits and local governments ...

Among patients with advanced PIK3CA-mutated, HR-positive/HER2-negative breast cancer, Itovebi-based treatment generated positive overall survival results.

Paolo Tarantino, MD, PhD, discusses the approval of the oral therapy elacestrant for patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer with ESR1 mutations.

Levi Garraway, Roche’s chief medical officer and head of global product development, said: “The INAVO120 overall survival ...

Patients diagnosed with more advanced breast cancer are more likely to have cardiovascular disease, a large study suggests.

Daiichi Sankyo Company, Ltd (TSE: 4568) has appointed Hiroyuki Okuzawa, 62, to succeed Sunao Manabe, DVM, Ph.D. as Chief ...

Morgan Stanley analyst Michael Ulz has maintained their neutral stance on ZNTL stock, giving a Hold rating yesterday.Invest with Confidence: ...